FDA Weighs In On Emergency Vaccine Authorization After Panel Gives Greenlight

The Food and Drug Administration is meeting Friday to decide whether to issue its emergency authorization to rollout the Pfizer coronavirus vaccine — which, if approved, could be available within weeks.

The recommendation does include caveats for people in several groups, including pregnant women and those who are allergic to the vaccine's components.

Dr. Leana Wen is a professor of public health at George Washington University and an emergency physician. She joins host Peter O'Dowd to talk about the new vaccine, as well as the vaccine by Sanofi and GlaxoSmithKline that has been delayed until the end of 2021.